Target intelligence / Profile preview

Hyperpolarization-activated cyclic nucleotide-gated potassium channel 2 pseudogene

Molecular classification
Other (pseudogene)
01

Overview

The ENSG00000259993 target encodes a pseudogene related to hyperpolarization-activated cyclic nucleotide-gated potassium channel 2 (HCN2). Pseudogenes are non-coding genomic sequences derived from ancestral genes and are generally considered non-functional in terms of protein-coding activity. In contrast, the functional HCN2 channel is an ion channel modulating neuronal and cardiac excitability, but this activity does not apply to the pseudogene. As such, ENSG00000259993 is not recognized as a drug target, has no associated therapeutic drugs or biomarkers, and holds no established disease relevance. Key caveat: Much of the literature and drug/biomarker knowledge pertains to HCN2 protein and its encoding gene, not the pseudogene ENSG00000259993. If your goal is to retrieve data on a therapeutic target, you should refer to the HCN2 gene itself (canonical name: Hyperpolarization-activated cyclic nucleotide-gated potassium channel 2, abbreviation: HCN2), an established ion channel involved in various pathologies. For the actual pseudogene ENSG00000259993, none of the typical drug target fields apply.

Other names
Hyperpolarization-activated cyclic nucleotide-gated potassium and sodium channel 2 pseudogeneLOC728424HCN2 pseudogene
02

Biological functions

Other (pseudogenes generally lack biological function; the functional HCN2 channel is involved in neuronal excitability, pacemaker activity, and rhythmicity, but this does not apply to the pseudogene)
03

Disease associations

Other (no established disease roles for the pseudogene; functional channel is implicated in neuropathic pain, neurodegenerative diseases, and some cancers, but again, not the pseudogene)

Beyond the preview

Go deeper on Hyperpolarization-activated cyclic nucleotide-gated potassium channel 2 pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hyperpolarization-activated cyclic nucleotide-gated potassium channel 2 pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call